These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 14981648

  • 1. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
    Berchi C, Bouvier V, Réaud JM, Launoy G.
    Health Econ; 2004 Mar; 13(3):227-38. PubMed ID: 14981648
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C, Benamouzig R, Spada C, Ponchon T, Zullo A, Saurin JC, Costamagna G.
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [Abstract] [Full Text] [Related]

  • 6. [Advantage of immunochemical fecal occult blood test in screening for colorectal cancer].
    Launoy G, Berchi C.
    Bull Cancer; 2005 Oct; 92(10):885-90. PubMed ID: 16266872
    [Abstract] [Full Text] [Related]

  • 7. High participation rates are not necessary for cost-effective colorectal cancer screening.
    Howard K, Salkeld G, Irwig L, Adelstein BA.
    J Med Screen; 2005 Oct; 12(2):96-102. PubMed ID: 15949121
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS, Leong AP, Leong TY.
    Stud Health Technol Inform; 2004 Oct; 107(Pt 1):104-10. PubMed ID: 15360784
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK, Ng SS, Leung MC, Sung JJ.
    Aliment Pharmacol Ther; 2008 Aug 01; 28(3):353-63. PubMed ID: 18638075
    [Abstract] [Full Text] [Related]

  • 13. Potential impact of population-based colorectal cancer screening in Canada.
    Flanagan WM, Le Petit C, Berthelot JM, White KJ, Coombs BA, Jones-McLean E.
    Chronic Dis Can; 2003 Aug 01; 24(4):81-8. PubMed ID: 14733756
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF, Russo MW, Biddle AK, Simpson KN, Ransohoff DF, Sandler RS.
    Am J Gastroenterol; 2000 Nov 01; 95(11):3250-8. PubMed ID: 11095350
    [Abstract] [Full Text] [Related]

  • 16. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ, Au F, Manns BJ, McGregor SE, Hilsden RJ.
    Clin Gastroenterol Hepatol; 2008 Aug 01; 6(8):912-917.e1. PubMed ID: 18534918
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Cost of a mass screening program for colorectal cancer using the occult blood test].
    Arveux P, Faivre J, Bedenne L, Durand G, Milan C, Milan C.
    Gastroenterol Clin Biol; 1992 Aug 01; 16(6-7):547-51. PubMed ID: 1526416
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.